1 Report prologue
2 Market Introduction
2.1 Definition 15
2.2 Scope of the Study 15
2.3 Assumptions & Limitations 16
2.3.1 Assumptions 16
2.3.2 Limitations 16
2.4 Market Structure 17
3 Research Methodology
3.1 Research Process 19
3.2 Primary Research 20
3.3 Secondary Research 21
3.4 Market Size Estimation 22
3.5 Forecast Model 22
4 Market Dynamics
4.1 Introduction 24
4.2 Drivers 26
4.2.1 Worldwide Rising Prevalence of Q fever Coupled with Increasing Q Fever Hospitalization Rates 26
4.2.2 Rising Worldwide Cattle, Sheep, and Goat Population 26
4.2.3 Growth in the Risk Factors of Q Fever 26
4.2.4 Globally Growing Geriatric Population 26
4.3 Restraints 27
4.3.1 High Cost of Diagnostic Tests 27
4.3.2 Lack of Awareness About Q Fever 27
4.4 Opportunity 27
4.4.1 Presence of Untapped Opportunities in the Asia-Pacific and African Regions 27
4.5 Market Trends 27
4.6 Macroeconomic Indicators 28
5 Market Factor Analysis
5.1 Porterโs Five Forces Model 30
5.1.1 Bargaining Power of Suppliers 30
5.1.2 Bargaining Power of Buyers 31
5.1.3 Threat of New Entrants 31
5.1.4 Threat of Substitutes 31
5.1.5 Rivalry 31
5.2 Supply Chain Analysis 32
5.2.1 R&D and Development 32
5.2.2 Manufacturing 32
5.2.3 Distribution & Sales 32
5.2.4 Post-Sales Monitoring 33
5.3 Investment Feasibility Analysis 33
5.4 Pricing Analysis 34
6 Global Q Fever Market, By Type
6.1 Overview 36
6.2 Acute 37
6.3 Chronic 37
7 Global Q Fever Market, By Diagnosis
7.1 Overview 39
7.2 Serology Tests 40
7.3 Others 40
8 Global Q Fever Market, By Treatment
8.1 Overview 42
8.2 Antibiotics 43
8.3 Surgery 43
9 Global Q Fever Market, By End-User
9.1 Overview 45
9.2 Patients 46
9.3 Hospitals 46
9.4 Others 47
10 Global Q Fever Market, By Region
10.1 Overview 49
10.2 Americas 51
10.2.1 North America 52
10.2.1.1 US 54
10.2.1.2 Canada 55
10.2.2 Latin America 56
10.3 Europe 57
10.3.1 Germany 59
10.3.2 France 60
10.3.3 UK 61
10.3.4 Italy 62
10.3.5 Spain 63
10.3.6 Rest of Europe 64
10.4 Asia-Pacific 65
10.4.1 Japan 67
10.4.2 China 68
10.4.3 India 69
10.4.4 Australia 70
10.4.5 South Korea 71
10.4.6 Rest of Asia-Pacific 72
10.5 Middle East & Africa 73
10.5.1 UAE 75
10.5.2 Saudi Arabia 76
10.5.3 Oman 77
10.5.4 Kuwait 78
10.5.5 Qatar 79
10.5.6 Africa 80
10.5.7 Rest of Middle East & Africa 81
11 Company Profile
11.1 Merck KGaA 83
11.1.1 Company Overview 83
11.1.2 Financial Overview 83
11.1.3 Products/Services Offered 83
11.1.4 SWOT Analysis 84
11.1.5 Key Developments 84
11.1.6 Key Strategies 84
11.2 Teva Pharmaceutical Industries Ltd 85
11.2.1 Company Overview 85
11.2.2 Financial Overview 85
11.2.3 Products/Services Offered 86
11.2.4 Key Developments 86
11.2.5 SWOT Analysis 86
11.2.6 Key Strategies 86
11.3 Pfizer Inc. 87
11.3.1 Company Overview 87
11.3.2 Financial Overview 87
11.3.3 Products/Services Offered 87
11.3.4 SWOT Analysis 88
11.3.5 Key Developments 88
11.3.6 Key Strategies 88
11.4 Basilea Pharmaceutica Ltd 89
11.4.1 Company Overview 89
11.4.2 Financial Overview 89
11.4.3 Products/Services Offered 90
11.4.4 Key Developments 90
11.4.5 SWOT Analysis 90
11.4.6 Key Strategies 90
11.5 Sanofi S. A. 91
11.5.1 Company Overview 91
11.5.2 Financial Overview 91
11.5.3 Products/Services Offered 91
11.5.4 SWOT Analysis 92
11.5.5 Key Developments 92
11.5.6 Key strategies 92
11.6 Melinta Therapeutics, Inc. 93
11.6.1 Company Overview 93
11.6.2 Financial Overview 93
11.6.3 Products/Services Offered 93
11.6.4 Key Developments 94
11.6.5 SWOT Analysis 94
11.6.6 Key Strategies 94
11.7 Bayer AG 95
11.7.1 Company Overview 95
11.7.2 Financial Overview 95
11.7.3 Products/Services Offered 95
11.7.4 SWOT Analysis 96
11.7.5 Key Developments 96
11.7.6 Key Strategies 96
11.8 Johnson & Johnson Services, Inc. 97
11.8.1 Company Overview 97
11.8.2 Financial Overview 97
11.8.3 Products/Services Offered 97
11.8.4 SWOT Analysis 98
11.8.5 Key Developments 98
11.8.6 Key Strategies 98
11.9 Yashica Pharmaceuticals 99
11.9.1 Company Overview 99
11.9.2 Financial Overview 99
11.9.3 Products/Services Offered 99
11.9.4 Key Developments 99
11.9.5 SWOT Analysis 100
11.9.6 Key Strategies 100
11.10 AtoxBio 101
11.10.1 Company Overview 101
11.10.2 Financial Overview 101
11.10.3 Products/Services Offered 101
11.10.4 Key Developments 101
11.10.5 SWOT Analysis 101
11.10.6 Key Strategies 101
12 Appendix
12.1 Discussion Blue Print 103
13 List of Tables
TABLE 1 PRIMARY INTERVIEWS 19
TABLE 2 TREATMENT COST FOR THE Q FEVER 24
TABLE 3 GLOBAL Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 36
TABLE 4 GLOBAL Q FEVER MARKET, FOR ACUTE BY REGION, 2020โ2027 (USD THOUSAND) 37
TABLE 5 GLOBAL Q FEVER MARKET, FOR CHRONIC BY REGION, 2020โ2027 (USD THOUSAND) 37
TABLE 6 GLOBAL Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 39
TABLE 7 GLOBAL Q FEVER MARKET, FOR SEROLOGY TESTS BY REGION, 2020โ2027 (USD THOUSAND) 40
TABLE 8 GLOBAL Q FEVER MARKET, FOR OTHERS BY REGION, 2020โ2027 (USD THOUSAND) 40
TABLE 9 GLOBAL Q FEVER MARKET, FOR ANTIBIOTICS BY REGION, 2020โ2027 (USD THOUSAND) 43
TABLE 10 GLOBAL Q FEVER MARKET, FOR SURGERY BY REGION, 2020โ2027 (USD THOUSAND) 43
TABLE 11 GLOBAL Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 45
TABLE 12 GLOBAL Q FEVER MARKET, FOR PATIENTS BY REGION, 2020โ2027 (USD THOUSAND) 46
TABLE 13 GLOBAL Q FEVER MARKET, FOR HOSPITALS BY REGION, 2020โ2027 (USD THOUSAND) 46
TABLE 14 GLOBAL Q FEVER MARKET, FOR OTHERS BY REGION, 2020โ2027 (USD THOUSAND) 47
TABLE 15 GLOBAL Q FEVER MARKET, BY REGION, 2020โ2027 (USD THOUSAND) 50
TABLE 16 AMERICAS: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 51
TABLE 17 AMERICAS: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 51
TABLE 18 AMERICAS: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 52
TABLE 19 AMERICAS: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 52
TABLE 20 NORTH AMERICA: Q FEVER MARKET, BY COUNTRY, 2020โ2027 (USD THOUSAND) 52
TABLE 21 NORTH AMERICAS: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 53
TABLE 22 NORTH AMERICAS: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 53
TABLE 23 NORTH AMERICAS: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 53
TABLE 24 NORTH AMERICAS: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 54
TABLE 25 US: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 54
TABLE 26 US: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 54
TABLE 27 US: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 54
TABLE 28 US: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 55
TABLE 29 CANADA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 55
TABLE 30 CANADA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 55
TABLE 31 CANADA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 55
TABLE 32 CANADA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 56
TABLE 33 LATIN AMERICA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 56
TABLE 34 LATIN AMERICA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 56
TABLE 35 LATIN AMERICA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 56
TABLE 36 LATIN AMERICA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 57
TABLE 37 EUROPE: Q FEVER MARKET, BY COUNTRY, 2020โ2027 (USD THOUSAND) 57
TABLE 38 EUROPE: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 58
TABLE 39 EUROPE: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 58
TABLE 40 EUROPE: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 58
TABLE 41 EUROPE: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 58
TABLE 42 GERMANY: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 59
TABLE 43 GERMANY: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 59
TABLE 44 GERMANY: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 59
TABLE 45 GERMANY: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 59
TABLE 46 FRANCE: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 60
TABLE 47 FRANCE: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 60
TABLE 48 FRANCE: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 60
TABLE 49 FRANCE: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 60
TABLE 50 UK: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 61
TABLE 51 UK: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 61
TABLE 52 UK: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 61
TABLE 53 UK: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 61
TABLE 54 ITALY: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 62
TABLE 55 ITALY: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 62
TABLE 56 ITALY: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 62
TABLE 57 ITALY: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 62
TABLE 58 SPAIN: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 63
TABLE 59 SPAIN: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 63
TABLE 60 SPAIN: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 63
TABLE 61 SPAIN: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 63
TABLE 62 REST OF EUROPE: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 64
TABLE 63 REST OF EUROPE: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 64
TABLE 64 REST OF EUROPE: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 64
TABLE 65 REST OF EUROPE: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 64
TABLE 66 ASIA-PACIFIC: Q FEVER MARKET, BY COUNTRY, 2020โ2027 (USD THOUSAND) 65
TABLE 67 ASIA-PACIFIC: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 65
TABLE 68 ASIA-PACIFIC: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 66
TABLE 69 ASIA-PACIFIC: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 66
TABLE 70 ASIA-PACIFIC: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 66
TABLE 71 JAPAN: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 67
TABLE 72 JAPAN: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 67
TABLE 73 JAPAN: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 67
TABLE 74 JAPAN: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 67
TABLE 75 CHINA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 68
TABLE 76 CHINA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 68
TABLE 77 CHINA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 68
TABLE 78 CHINA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 68
TABLE 79 INDIA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 69
TABLE 80 INDIA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 69
TABLE 81 INDIA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 69
TABLE 82 INDIA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 69
TABLE 83 AUSTRALIA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 70
TABLE 84 AUSTRALIA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 70
TABLE 85 AUSTRALIA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 70
TABLE 86 AUSTRALIA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 70
TABLE 87 SOUTH KOREA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 71
TABLE 88 SOUTH KOREA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 71
TABLE 89 SOUTH KOREA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 71
TABLE 90 SOUTH KOREA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 71
TABLE 91 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 72
TABLE 92 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 72
TABLE 93 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 72
TABLE 94 REST OF ASIA-PACIFIC: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 72
TABLE 95 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY COUNTRY, 2020โ2027 (USD THOUSAND) 73
TABLE 96 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 74
TABLE 97 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 74
TABLE 98 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 74
TABLE 99 MIDDLE EAST & AFRICA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 74
TABLE 100 UAE: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 75
TABLE 101 UAE: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 75
TABLE 102 UAE: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 75
TABLE 103 UAE: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 75
TABLE 104 SAUDI ARABIA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 76
TABLE 105 SAUDI ARABIA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 76
TABLE 106 SAUDI ARABIA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 76
TABLE 107 SAUDI ARABIA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 76
TABLE 108 OMAN: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 77
TABLE 109 OMAN: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 77
TABLE 110 OMAN: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 77
TABLE 111 OMAN: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 77
TABLE 112 KUWAIT: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 78
TABLE 113 KUWAIT: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 78
TABLE 114 KUWAIT: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 78
TABLE 115 KUWAIT: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 78
TABLE 116 QATAR: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 79
TABLE 117 QATAR: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 79
TABLE 118 QATAR: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 79
TABLE 119 QATAR: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 79
TABLE 120 AFRICA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 80
TABLE 121 AFRICA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 80
TABLE 122 AFRICA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 80
TABLE 123 AFRICA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 80
TABLE 124 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TYPE, 2020โ2027 (USD THOUSAND) 81
TABLE 125 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY DIAGNOSIS, 2020โ2027 (USD THOUSAND) 81
TABLE 126 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 81
TABLE 127 REST OF MIDDLE EAST & AFRICA: Q FEVER MARKET, BY END USER, 2020โ2027 (USD THOUSAND) 81
14 List of Figures
FIGURE 1 GLOBAL Q FEVER MARKET: MARKET STRUCTURE 17
FIGURE 2 RESEARCH PROCESS 19
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 22
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL Q FEVER MARKET 25
FIGURE 5 PORTERโS FIVE FORCES ANALYSIS: GLOBAL Q FEVER MARKET 30
FIGURE 6 SUPPLY CHAIN: GLOBAL Q FEVER MARKET 32
FIGURE 7 GLOBAL Q FEVER MARKET SHARE, BY TYPE, 2020 (%) 36
FIGURE 8 GLOBAL Q FEVER MARKET, BY TYPE, 2020 & 2027 (USD THOUSAND) 37
FIGURE 9 GLOBAL Q FEVER MARKET SHARE, BY DIAGNOSIS, 2020 (%) 39
FIGURE 10 GLOBAL Q FEVER MARKET, BY DIAGNOSIS, 2020 & 2027 (USD THOUSAND) 40
FIGURE 11 GLOBAL Q FEVER MARKET, BY TREATMENT, 2020โ2027 (USD THOUSAND) 42
FIGURE 12 GLOBAL Q FEVER MARKET SHARE, BY TREATMENT, 2020 (%) 42
FIGURE 13 GLOBAL Q FEVER MARKET, BY TREATMENT, 2020 & 2027 (USD THOUSAND) 43
FIGURE 14 GLOBAL Q FEVER MARKET SHARE, BY END USER, 2020 (%) 45
FIGURE 15 GLOBAL Q FEVER MARKET, BY END USER, 2020 & 2027 (USD THOUSAND) 46
FIGURE 16 GLOBAL Q FEVER MARKET SHARE, BY REGION, 2020 (%) 50
FIGURE 17 AMERICAS: Q FEVER MARKET SHARE, BY REGION, 2020 (%) 51
FIGURE 18 NORTH AMERICA: Q FEVER MARKET SHARE, BY COUNTRY, 2020 (%) 53
FIGURE 19 EUROPE: Q FEVER MARKET SHARE, BY COUNTRY, 2020 (%) 57
FIGURE 20 ASIA-PACIFIC: Q FEVER MARKET SHARE, BY COUNTRY, 2020 (%) 65
FIGURE 21 MIDDLE EAST & AFRICA: Q FEVER MARKET SHARE, BY COUNTRY, 2020 (%) 73